Status:
COMPLETED
OPTimizing Treatment Focused Genetic Testing IN Cancer
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Breast Cancer
Ovarian Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This two-part randomized controlled trial aims to evaluate the impact of pre-test video education as compared to pre-test Chatbot education.
Detailed Description
In this research study, the investigators are introducing the option of two alternatives to genetic counseling before genetic testing: Chatbot and video education. The first part of this research stu...
Eligibility Criteria
Inclusion
- Adult patients over the age of 18
- With a diagnosis of advanced cancer (defined as Stage 3 or 4), or
- Any stage for pancreatic cancer and
- No prior cancer genetic panel testing
Exclusion
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women (if known at the time of participation)
- Prisoners
- Non-English speakers
Key Trial Info
Start Date :
December 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT04066361
Start Date
December 19 2019
End Date
November 30 2022
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115